STADA Arzneimittel AG
SAZ | HM
Overview
Corporate Details
- ISIN(s):
- DE0007251803 (+1 more)
- LEI:
- 529900FMTTLMH0P0DL10
- Country:
- Germany
- Address:
- Stadastraße 2 - 18, 61118 Bad Vilbel
- Website:
- https://www.stada.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally. STADA focuses on a three pillar strategy consisting of generics, specialty pharma and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-02-23 14:15 |
Report Publication Announcement
|
English | 3.9 KB | |
| 2023-02-23 11:25 |
Report Publication Announcement
|
English | 4.0 KB | |
| 2022-08-17 09:49 |
Report Publication Announcement
|
English | 4.0 KB | |
| 2022-03-14 10:18 |
Report Publication Announcement
|
English | 3.7 KB | |
| 2022-03-14 10:15 |
Report Publication Announcement
|
English | 3.7 KB | |
| 2021-08-18 12:41 |
Report Publication Announcement
|
English | 3.8 KB | |
| 2021-03-03 09:38 |
Report Publication Announcement
|
English | 3.7 KB | |
| 2021-03-03 09:35 |
Report Publication Announcement
|
English | 3.7 KB | |
| 2020-09-16 15:05 |
General Meeting Notice
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Haupt…
|
German | 5.2 KB | |
| 2020-08-17 15:05 |
General Meeting Notice
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Haupt…
|
German | 54.0 KB | |
| 2020-08-10 10:16 |
Report Publication Announcement
|
English | 3.8 KB | |
| 2020-04-20 15:07 |
General Meeting Notice
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Haupt…
|
German | 48.6 KB | |
| 2020-03-10 16:46 |
Report Publication Announcement
|
English | 4.4 KB | |
| 2020-02-21 13:07 |
Foreign Filer Report
Release of the Home Member State according to Article 5 of the WpHG [the German…
|
English | 2.9 KB | |
| 2019-08-07 11:55 |
Report Publication Announcement
|
English | 1.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |